Follow
Ozlen Atug, MD, Prof.
Ozlen Atug, MD, Prof.
Marmara University School of Medicine
Verified email at marmara.edu.tr
Title
Cited by
Cited by
Year
Vedolizumab as induction and maintenance therapy for ulcerative colitis
BG Feagan, P Rutgeerts, BE Sands, S Hanauer, JF Colombel, ...
New England Journal of Medicine 369 (8), 699-710, 2013
25562013
Vedolizumab as induction and maintenance therapy for Crohn's disease
WJ Sandborn, BG Feagan, P Rutgeerts, S Hanauer, JF Colombel, ...
New England Journal of Medicine 369 (8), 711-721, 2013
22852013
Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey
N Tozun, O Atug, N Imeryuz, HO Hamzaoglu, A Tiftikci, E Parlak, U Dagli, ...
Journal of clinical gastroenterology 43 (1), 51-57, 2009
1682009
The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease
O Yanartas, HT Kani, E Bicakci, I Kilic, M Banzragch, C Acikel, O Atug, ...
Neuropsychiatric Disease and Treatment, 673-683, 2016
762016
Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease
Y Yilmaz, E Ulukaya, OO Gul, M Arabul, CB Gul, O Atug, AY Oral, S Aker, ...
Clinical biochemistry 42 (9), 802-807, 2009
732009
Association between the presence of brown adipose tissue and non‐alcoholic fatty liver disease in adult humans
Y Yilmaz, T Ones, T Purnak, S Ozguven, R Kurt, O Atug, HT Turoglu, ...
Alimentary pharmacology & therapeutics 34 (3), 318-323, 2011
712011
Melatonin ameliorates methionine‐and choline‐deficient diet‐induced nonalcoholic steatohepatitis in rats
V Tahan, O Atug, H Akin, F Eren, G Tahan, O Tarcin, H Uzun, O Ozdogan, ...
Journal of pineal research 46 (4), 401-407, 2009
662009
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials
DT Rubin, I Dotan, A DuVall, Y Bouhnik, G Radford-Smith, PDR Higgins, ...
The lancet Gastroenterology & hepatology 7 (1), 17-27, 2022
652022
Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance
Y Yilmaz, E Ulukaya, O Atug, E Dolar
European journal of gastroenterology & hepatology 21 (11), 1247-1251, 2009
652009
Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease
F Eren, R Kurt, F Ermis, O Atug, N Imeryuz, Y Yilmaz
Clinical biochemistry 45 (9), 655-658, 2012
602012
Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis
A Tiftikci, O Atug, Y Yilmaz, F Eren, FT Ozdemir, S Yapali, O Ozdogan, ...
Archives of Medical Research 40 (4), 294-298, 2009
432009
Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease
Y YilmazABDEFG, O AtugDEF, O YonalEF, D DumanADE, O OzdoganD, ...
Med Sci Monit 15 (4), 5, 2009
412009
Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity
Y Yilmaz, O Yonal, F Eren, O Atug, H Over Hamzaoglu
Journal of Crohn's and Colitis 5 (5), 402-406, 2011
362011
Critical pH level of lye (NaOH) for esophageal injury
O Atug, A Dobrucali, RC Orlando
Digestive diseases and sciences 54, 980-987, 2009
262009
Incidence rate of anemia in inflammatory bowel diseases
Ö Atuğ, HT Kani, M Banzragch, N İmeryüz, H Akın
Turk J Gastroenterol 27 (2), 143-148, 2016
252016
Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease
Y Yilmaz, O Ozturk, YO Alahdab, E Senates, Y Colak, HL Doganay, ...
Digestive and Liver Disease 45 (1), 58-62, 2013
252013
Association between bactericidal/permeability increasing protein (BPI) gene polymorphism (Lys216Glu) and inflammatory bowel disease
H Akın, G Tahan, F Türe, F Eren, Ö Atuğ, V Tahan, İ Hamzaoğlu, ...
Journal of Crohn's and Colitis 5 (1), 14-18, 2011
252011
Preliminary evidence of an association between the functional c‐kit rs6554199 polymorphism and achalasia in a Turkish population
YO Alahdab, F Eren, A Giral, F Gunduz, AE Kedrah, O Atug, Y Yilmaz, ...
Neurogastroenterology & Motility 24 (1), 27-30, 2012
242012
Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARgamma) gene in inflammatory bowel disease
O Atug, V Tahan, F Eren, A Tiftikci, N Imeryuz, HO Hamzaoglu, N Tozun
J Gastrointestin Liver Dis 17 (4), 433-437, 2008
232008
Evaluation of depression, anxiety, alexithymia, attachment, social support and somatization in functional dyspepsia
HT Kani, U Dural, A Sakalli Kani, O Yanartas, S Kiziltas, F Yilmaz Enc, ...
Psychiatry and Clinical Psychopharmacology 29 (1), 45-51, 2019
172019
The system can't perform the operation now. Try again later.
Articles 1–20